T
Tempus
A technology company advancing precision medicine through the practical application of artificial intelligence in healthcare
At a glance
- Founded
- 2015
- Headquarters
- Chicago, United States
- Listing
- IPO 2024
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Latest news
Press, funding announcements and product moves mentioning Tempus.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- LILightbank
Series B and later8 investors entered at this stage
Baillie Gifford
T. Rowe Price- RERevolution
Alphabet | Google
NEA- NHNovo Holdings
- KCKinship Trust Co.
Franklin Templeton Investments
Source: Dealroom Talent Intelligence.
Alumni founders
Former Tempus employees who went on to found companies, sorted by Dealroom signal score.
WEWeaveEst. 2023
Ari CarolineUnited States
Sasha GribovUnited States
Aadel ChaudhuriUnited States
PAPathosEst. 2022
Eric LefkofskyUnited States
PSPayall Payment SystemsEst. 2018
Gary PalmerUnited StatesGlobal footprint
team presence
across markets
Patents
269 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Tempus was the backer or acquirer, 2018–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
4 deals across Tempus's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Where Tempus deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
Tempus's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Tempus on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Tempus on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.